Castle Creek Biosciences Company

Castle Creek Biosciences is a privately held, clinical-stage cell and gene therapy company that focused on developing and commercializing disease-modifying therapies for patients suffering from orphan conditions where there are high unmet needs due to a lack of available treatment options. The company’s approach to personalized biologics is distinctive based on our proprietary, autologous fibroblast technology platform. By extracting fibroblast cells from a patient’s skin, they create localized treatments that are compatible with the unique biology of each patient and have the potential to address the underlying cause of the disease.

Headquarters: United States
Founded Date: 2015
Technology: Autologous Stem Cells for Face Skin Rejuvenation
Employee Number: 11-50